Dilated Optic Nerve Sheath in Mucopolysaccharidosis I: Common and Not Necessarily High Intracranial Pressure

References

1. 1.↵
   1. Alden TD,
   2. Amartino H,
   3. Dalla Corte A, et al

   . Surgical management of neurological manifestations of mucopolysaccharidosis disorders. Mol Genet Metab 2017;122:41–48 doi:10.1016/j.ymgme.2017.09.011 pmid:29153846

   CrossRefPubMed
2. 2.↵
   1. Aldenhoven M,
   2. Wynn RF,
   3. Orchard PJ, et al

   . Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood 2015;125:2164–72 doi:10.1182/blood-2014-11-608075 pmid:25624320

   Abstract/FREE Full Text
3. 3.↵
   1. Kishk NA,
   2. Ebraheim AM,
   3. Ashour AS, et al

   . Optic nerve sonographic examination to predict raised intracranial pressure in idiopathic intracranial hypertension: the cut-off points. Neuroradiol J 2018;31:490–95 doi:10.1177/1971400918789385 pmid:30024291

   CrossRefPubMed
4. 4.↵
   1. Munawar K,
   2. Khan MT,
   3. Hussain SW, et al

   . Optic nerve sheath diameter correlation with elevated intracranial pressure determined via ultrasound. Cureus 2019;11:e4145 doi:10.7759/cureus.4145 pmid:31058028

   CrossRefPubMed
5. 5.↵
   1. Kapoor KG,
   2. Katz SE,
   3. Grzybowski DM, et al

   . Cerebrospinal fluid outflow: an evolving perspective. Brain Res Bull 2008;77:327–34 doi:10.1016/j.brainresbull.2008.08.009 pmid:18793703

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Schumacher RG,
   2. Brzezinska R,
   3. Schulze-Frenking G, et al

   . Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI. Pediatr Radiol 2008;38:543–50 doi:10.1007/s00247-008-0788-y pmid:18299822

   CrossRefPubMed
7. 7.↵
   1. Muenzer J,
   2. Wraith JE,
   3. Clarke LA

   ; International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009;123:19–29 doi:10.1542/peds.2008-0416 pmid:19117856

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Kubaski F,
   2. de Oliveira Poswar F,
   3. Michelin-Tirelli K, et al

   . Mucopolysaccharidosis type I. Diagnostics 2020;10:161 doi:10.3390/diagnostics10030161 pmid:32188113

   CrossRefPubMed
9. 9.↵
   1. Raymond GV,
   2. Pasquali M,
   3. Polgreen LE, et al

   . Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H. Sci Rep 2016;6:38305 doi:10.1038/srep38305 pmid:27910891

   CrossRefPubMed
10. 10.↵
    1. Lochner P,
    2. Czosnyka M,
    3. Naldi A, et al

    . Optic nerve sheath diameter: present and future perspectives for neurologists and critical care physicians. Neurol Sci 2019;40:2447–57 doi:10.1007/s10072-019-04015-x pmid:31367861

    CrossRefPubMed
11. 11.↵
    1. Vaiman M,
    2. Abuita R,
    3. Bekerman I

    . Optic nerve sheath diameters in healthy adults measured by computer tomography. Int J Ophthalmol 2015;8:1240–44 doi:10.3980/j.issn.2222-3959.2015.06.30 pmid:26682181

    CrossRefPubMed
12. 12.↵
    1. Janthanimi P,
    2. Dumrongpisutikul N

    . Pediatric optic nerve and optic nerve sheath diameter on magnetic resonance imaging. Pediatr Radiol 2019;49:1071–77 doi:10.1007/s00247-019-04404-6 pmid:31049608

    CrossRefPubMed
13. 13.↵
    1. Shofty B,
    2. Ben-Sira L,
    3. Constantini S, et al

    . Optic nerve sheath diameter on MR imaging: establishment of norms and comparison of pediatric patients with idiopathic intracranial hypertension with healthy controls. AJNR Am J Neuroradiol 2012;33:366–69 doi:10.3174/ajnr.A2779 pmid:22116116

    Abstract/FREE Full Text
14. 14.↵
    1. Gratton SM,
    2. Neerukonda T

    . Mucopolysaccharidosis type 1 and bilateral optic disc edema. Neuroophthalmology 2019;43:394–96 doi:10.1080/01658107.2018.1520903 pmid:32165899

    CrossRefPubMed
15. 15.↵
    1. Summers CG,
    2. Ashworth JL

    . Ocular manifestations as key features for diagnosing mucopolysaccharidoses. Rheumatology (Oxford) 2011;50:v34–40 doi:10.1093/rheumatology/ker392 pmid:22210668

    CrossRefPubMed
16. 16.↵
    1. Al-Haddad CE,
    2. Sebaaly MG,
    3. Tutunji RN, et al

    . Optic nerve measurement on MRI in the pediatric population: normative values and correlations. AJNR Am J Neuroradiol 2018;39:369–74 doi:10.3174/ajnr.A5456 pmid:29217740

    Abstract/FREE Full Text
17. 17.↵
    1. Ellis R

    . Lumbar cerebrospinal fluid opening pressure measured in a flexed lateral decubitus position in children. Pediatrics 1994;93:622–23 doi:10.1542/peds.93.4.622 pmid:8134218

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Avery RA

    . Reference range of cerebrospinal fluid opening pressure in children: historical overview and current data. Neuropediatrics 2014;45:206–11 doi:10.1055/s-0034-1376202 pmid:24867260

    CrossRefPubMed
19. 19.↵
    1. Avery RA,
    2. Shah SS,
    3. Licht DJ, et al

    . Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med 2010;363:891–93 doi:10.1056/NEJMc1004957 pmid:20818852

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Bursztyn LL,
    2. Sharan S,
    3. Walsh L, et al

    . Has rising pediatric obesity increased the incidence of idiopathic intracranial hypertension in children? Can J Ophthalmol 2014;49:87–91 doi:10.1016/j.jcjo.2013.09.015 pmid:24513363

    CrossRefPubMed
21. 21.↵
    1. Matthews YY,
    2. Dean F,
    3. Lim MJ, et al

    . Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child 2017;102:715–21 doi:10.1136/archdischild-2016-312238 pmid:28356250

    Abstract/FREE Full Text